Safety and immunogenicity of a Nipah virus vaccine (HeV-sG-V) in adults: a single-centre, randomised, observer-blind, placebo-controlled, phase 1 study
Robert W. Frenck, Abdi Naficy, Jodi Feser, Michelle P Dickey, Victor H. Leyva-Grado, Michael A. Egan, Tracy Chen, John H. Eldridge, Susan Sciotto-Brown, Luz Hermida, Dominique Promeneur, Amara Luckay, Herbert Medina, Glorie-Grace A Lazaro, Nairuti R Patel, Tahira Naqvi, Christopher C. Broder, Antony S. Dimitrov, Christopher Gast, Laina D. Mercer, Michael Raine, Indah Andi-Lolo, Bruce L. Innis, John J Aponte, Stefan Hamm, Niraj Rathi
Topics & Concepts
ImmunogenicityVirologyPreparednessMedicineAntibody responseVaccinationPhase (matter)BiologyVaccine safetyVirusSeroconversionAntibodyImmunizationCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Mass vaccinationDuck embryo vaccine2019-20 coronavirus outbreakImmunologyImmunityOutbreakVirology and Viral DiseasesImmune responses and vaccinationsRespiratory viral infections research